Assessment of Cognitive Function and Exercise Capacity in Cystic Fibrosis

Hacettepe University

Status: Completed

Conditions: Cystic Fibrosis

Study type: Observational

Funder types: Other

Identifiers

NCT06175182

GO 22/917

Details and patient eligibility

About

No studies in the literature have investigated the simultaneous effects of cognitive function, exercise capacity and arterial stiffness in adult patients with CF. The study aims to compare the cognitive function, exercise capacity, exercise muscle oxygenation, and arterial stiffness of adult patients with CF and healthy subjects.

Full description

Cystic fibrosis (CF) affects other body systems as well as the respiratory system. Patients with CF seem to have reduced exercise capacity, which is a major contributor to mortality rates. Changes in lung function, ventilatory dysfunction, and respiratory muscle function potentially contribute to exercise intolerance in CF. Both children and adults with CF exhibit neurocognitive dysfunction. Arterial stiffness is a predictor of cardiovascular events, including myocardial infarction, heart failure, and mortality. Individuals with CF exhibit an increase in arterial stiffness. However, no studies in the literature have investigated cognitive function, exercise capacity, and arterial stiffness coexistence in adult CF patients. The study aims to compare the cognitive function, exercise capacity, exercise muscle oxygenation and arterial stiffness in adult patients with CF and healthy subjects. Additionally, it will determine the relationship between cognitive function and arterial stiffness with exercise capacity and muscle oxygenation during exercise in adult patients with CF.

Enrollment: 48 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Having been diagnosed with cystic fibrosis
• Being 18 years old and older
• Clinically stable condition
• Able to cooperate with the tests performed
• Volunteered to participate in the study

For the control group:

• Being 18 years old and older
• Volunteered to participate in the study

Exclusion criteria

• History of hospitalization or exacerbation in the last month.
• Chronic respiratory failure and long-term use of oxygen therapy
• Using noninvasive mechanical ventilator therapy
• Indication for lung transplantation
• Who had a lung transplant
• Forced expiratory volume in the first second (FEV1) value 30% and below
• CF-related diabetes
• Chronic liver disease
• Allergic bronchopulmonary aspergillosis
• Systemic steroid use
• History of diagnosed orthopedic or musculoskeletal problems affecting mobility
• Cardiovascular instability
• Serious psychiatric illness

For the control group:

• Known chronic or systemic disease
• Who did not volunteer to participate in the study

Trial design

48 participants in 2 patient groups

cystic fibrosis

Description:

No intervention

healthy volunteers

Description:

No intervention